The World Health Organization listed AstraZeneca’s Covid-19 vaccine for emergency use, widening access in the developing world, while sources said the EU is in talks with Moderna on buying more vaccines.
China approved a Covid-19 vaccine developed by an affiliate of state-backed pharmaceutical giant Sinopharm on Dec. 31, the country’s first approved shot for general public use as it braces for increased transmission risks over winter.
Sinopharm announced that the Chinese biopharmaceutical company’s Covid-19 vaccine candidate had an efficacy rate of 79% based on interim analysis of Phase III trials.
